Gossamer Bio, Inc.
GOSS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9 | $26 | $29 | $46 |
| Short-Term Investments | $171 | $187 | $229 | $248 |
| Receivables | $10 | $8 | $7 | $5 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $14 | $15 | $11 | $10 |
| Total Curr. Assets | $204 | $236 | $275 | $310 |
| Property Plant & Equip (Net) | $4 | $5 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $5 | $5 | $5 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $209 | $241 | $281 | $315 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $3 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $24 | $23 | $18 | $17 |
| Other Curr. Liab. | $36 | $27 | $26 | $25 |
| Total Curr. Liab. | $62 | $54 | $48 | $45 |
| LT Debt | $202 | $202 | $202 | $202 |
| Deferred Rev, NC | $27 | $31 | $37 | $39 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $229 | $233 | $239 | $241 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $5 | $5 |
| Total Liabilities | $291 | $287 | $287 | $286 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,392 | -$1,343 | -$1,305 | -$1,269 |
| AOCI | -$5 | -$5 | -$1 | $1 |
| Other Equity | $1,314 | $1,302 | $1,300 | $1,297 |
| Total Equity | -$82 | -$46 | -$6 | $29 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $209 | $241 | $281 | $315 |
| Net Debt | $194 | $177 | $174 | $157 |